Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BISER
NCT02268006Phase 2Unknown
- Sponsor
- Institute of Oncology Ljubljana
- Start
- Jan 2014
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in rectal adenocarcinoma, sponsored by Institute of Oncology Ljubljana. Primary endpoint: Pathological complete remission rate. Status: unknown.
02
Conditions
rectal adenocarcinoma
Beyond the preview
Go deeper on NCT02268006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02268006.